Shuanglin Qin | Chemical Biology | Best Researcher Award

Posted on by chemical Scientist

Prof. Shuanglin Qin | Chemical Biology | Best Researcher Award

Professor at Hunan University of Chinese Medicine , China.

Professor Shuanglin Qin 👨‍🔬, born on October 1, 1989 🎂, is a prominent researcher at the Research Center for Precision Medication of Chinese Medicine, Hunan University of Chinese Medicine 🏫. With a Ph.D. in Chemical Biology 🎓, his research focuses on anti-cancer drug discovery and traditional Chinese medicinal compounds 💊🌿. Known for his excellence in natural product-based drug development, he has earned notable accolades such as the Hunan Distinguished Young Scholars award 🏅. Prof. Qin also serves as an editorial member for prestigious journals 📚 and actively contributes to advancing chemical biology and precision medicine 🔬✨.

PROFILE 

ORCID 

SCOPUS 

🔍 Summary of Suitability:

Professor Shuanglin Qin demonstrates exceptional research caliber, leadership, and consistent scholarly impact in the fields of chemical biology and anti-cancer drug discovery. His academic journey reflects steady growth from student to professor, with groundbreaking work in natural product-based therapeutics rooted in Traditional Chinese Medicine 🌿. He has earned competitive national and provincial funding, secured editorial roles in top-tier journals, and actively contributed to the peer-review ecosystem of global scientific publications 🌍📚. These achievements mark him as a leader in his field and an ideal candidate for the Best Researcher Award.

🎓 Education & 🧪 Experience 

🎓 Education:

  • 📍 2016–2019: Ph.D., School of Pharmaceutical Science and Technology, Tianjin University

  • 📍 2013–2016: Master’s, School of Pharmacy, Jiangxi Science & Technology Normal University

  • 📍 2009–2013: Bachelor’s, School of Pharmacy, Hunan University of Chinese Medicine

🧪 Experience:

  • 🧑‍🏫 2024–2025: Professor, Hunan University of Chinese Medicine

  • 🧑‍🏫 2019–2024: Associate Professor, Hubei University of Science and Technology

Professional Development 🚀📖

Professor Shuanglin Qin is committed to continual professional advancement 🌟. As a principal investigator, he has led numerous high-impact projects under national and provincial funding programs, including the National Natural Science Foundation of China 💼🔬. He actively collaborates across disciplines to explore mechanisms of natural product-derived drugs. His editorial contributions span journals like the Journal of Oncology and Traditional Medicine Research 📝📊. As a peer reviewer for renowned scientific outlets, he ensures the integrity of research dissemination 🔍. His work fosters innovation in traditional Chinese medicine and strengthens links between academia and healthcare industries globally 🌍🧠.

Research Focus 🔍🤖

Professor Qin’s research primarily focuses on chemical biology and anti-cancer drug discovery 🧪🧬. He explores the molecular mechanisms of action and therapeutic potentials of natural products derived from traditional Chinese medicine 🌿💊. His interdisciplinary approach combines pharmacology, biochemistry, and medicinal chemistry to identify novel bioactive compounds targeting tumors 🎯. His efforts are directed toward developing precision medications with high efficacy and minimal side effects 🧠⚕️. By bridging modern technology with ancient remedies, his research significantly advances cancer therapeutics and natural product innovation 🔄🌱. His lab continues to pave the way in translational cancer research and drug development 🚀.

Awards and Honors 🏆🎖️

  • 🥇 Winner, Hunan Science Fund for Distinguished Young Scholars

  • 🏅 Winner, ChuTian Scholars Program, Hubei Province

  • 📊 Principal Investigator, National Natural Science Foundation of China projects

  • 🧪 Recipient, China Postdoctoral Science Foundation funding

  • 📘 Recognized in Youth Talent Programs by Hubei Health Commission & Education Department

  • 📝 Editorial roles in Journal of Oncology, Traditional Medicine Research, Life Research, and Medical Data Mining

  • 🔍 Reviewer for journals like European Journal of Medicinal Chemistry and Frontiers in Cell and Developmental Biology

Publications & Citations 📚

  • 📊 “Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study” – Ye Luo et al., Acta Pharmaceutica Sinica B, 2025 | 📅 2025 | 📑 Cited by: 1

  • 🧬 “PROTACs coupled with oligonucleotides to tackle the undruggable” – Guangshuai Zhang et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 0

  • 🌿 “Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation” – Xingyun Liu et al., BMC Complementary Medicine and Therapies, 2024 | 📅 2024 | 📑 Cited by: 2

  • 🔬 “PROTAC technology: From drug development to probe technology for target deconvolution” – Si Yan et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 19

🔍 Conclusion:

Professor Qin’s dedication to translational cancer research, deep-rooted knowledge in natural product chemistry, and outstanding scientific contributions make him a model researcher in his domain. His influence spans innovation, education, and publication, fulfilling the highest standards for a Best Researcher Award recipient. He exemplifies not just academic productivity, but also real-world impact in advancing healthcare through traditional knowledge and modern science fusion.

 

 

SUNRAY LEE | Molecular Biology | Best Researcher Award

Posted on by chemical Scientist

Ms. SUNRAY LEE | Molecular Biology | Best Researcher Award

Research Director at CEFObio Co., Ltd , South Korea.

Dr. Sunray Lee is a distinguished researcher and Director of CEFO Research Institute in Seoul, Korea 🇰🇷. With a Ph.D. in Stem Cell Biology from Korea University 🎓, his expertise spans molecular immunology, MHC biology, and regenerative medicine 🧬. Over two decades, he has led pivotal R&D in stem cells, biomaterials, and cell therapy 🧪. As a prolific author and patent holder, Dr. Lee’s innovations have influenced cosmetic biotechnology, bone regeneration, and 3D cell culture 🌿🧫. He is a regular member of national innovation committees and an active contributor to international conferences and regenerative medicine networks 🌍.

PROFILE 

orcid

🔍 Summary of Suitability:

Dr. Sunray Lee embodies the ideal candidate for a Best Researcher Award through his unmatched dedication, multidisciplinary expertise, and leadership in regenerative medicine, stem cell biology, and biomaterials research. With over 20 years of experience and numerous high-impact publications, his work bridges science and innovation, directly contributing to advancements in clinical and cosmetic therapeutics. He has led transformative R&D, mentored scientific communities, and represented Korea in international regenerative medicine collaborations.

🎓 Education

  • B.Sc. in Agronomy – Korea University (1995–1999) 🌾

  • M.Sc. in Molecular & Cellular Immunology – Korea University (2000–2003) 🧫

  • Ph.D. in MHC & Stem Cell Biology – Korea University (2006–2012) 🧬

💼 Professional Experience

  • 🔬 Researcher, MHC Lab, Seoul National University (2004–2005)

  • 🧪 Senior Scientist, MizMedi Hospital (2005–2007)

  • 🧫 Senior Scientist, MCTT Research Institute (2007–2011)

  • 🧠 Member, KEIT Innovation Evaluation (2010–2025)

  • 🧬 Director, CEFO Research Institute (2012–Present)

  • 🔗 Committee Member, KSMCB, KSB, KSSCR, CARM, APACRM (2017–Present)

Professional Development 🚀📖

Dr. Sunray Lee’s professional growth is rooted in cross-disciplinary research, collaborative leadership, and regulatory insight 📚🔬. He is deeply involved in Korea’s R&D planning and policy through KEIT and serves as Vice Chair at CARM’s International Cooperation Committee 🌐🤝. His participation in global forums like APACRM and KSSCR highlights his dedication to regenerative medicine diplomacy 🌱💬. Dr. Lee frequently delivers keynote talks and publishes cutting-edge research in journals spanning biomedical engineering, dermatology, and pharmaceuticals 📖🗣️. He continuously fosters innovation through industry-academia linkages and promotes ethical advancement in biotechnology and stem cell research 🌍⚙️.

Research Focus 🔍🤖

Dr. Lee’s research revolves around regenerative medicine, focusing on stem cell biology, biomaterials, and cellular therapy 🧬🧪. His work includes developing 3D cell culture systems, cryopreservation methods, and stem cell-based skin and bone therapies 🧫🦴. A major emphasis lies in mesenchymal stem cells, pluripotent stem cells, and their therapeutic applications in cosmetics and orthopedics 🧖‍♀️⚕️. His projects combine bioengineering, molecular biology, and omics to optimize cell culture environments and develop innovative treatment platforms 🔍🔧. With a vision toward translational medicine, he contributes to national and international standards for advanced regenerative products and clinical protocols 🌐🧠.

Awards and Honors 🏆🎖️

  • 🏅 Citation by Ministry of Trade, Industry & Energy (MOTIE) – Dec. 12, 2018

  • 🥇 Best Investigator Award, Korea University – Mar. 27, 2012

Publications & Citations 📚

    • 2025 – 🧪 Development of Mold Technology for Insert-Wells

    • 2024 – 🧬 Cell Therapy Using Umbilical Cord MSCs for Osteonecrosis

    • 2023 – 🦴 Osteogenic-Induced Adipose Stem Cells in Canine Bone Repair

    • 2023 – 💧 Stem Cell-Conditioned Medium for Whitening & Moisturizing

    • 2023 – 🧫 Tracking HUVECs Using Quantum Dot Nanoparticles

    • 2023 – 🌏 Asia Guidelines for Ancillary Materials in Cell Therapy

    • 2022 – ❄️ Cryogenic Storage Container Cell Viability Study

    • 2022 – 💆 3D Stem Cell Cream Effects on Skin Elasticity

    • 2020 – 🌿 Anti-aging Effects of Stem Cell Creams

    • 2020 – 🧬 Medroxyprogesterone & Metformin in Endometrial Cancer

    • 2020 – ❄️ Cryogenic Container Plastic Changes Analysis

    • 2020 – 💊 3D Co-culture to Enhance Drug Selectivity

    • 2020 – 🧴 Cosmetic Products with MSC Medium

    • 2019 – 🐎 Equine iPSCs for Therapeutic MSC Differentiation

    • 2019 – 🛡️ Immune Effects of 3D MSC Conditioned Cream

    • 2018 – 💪 Induced Myogenic Stem Cells via Transcription Factors

    • 2016 – 💉 Apoptin Gene Delivery for Glioma Cells

    • 2016 – 🧬 Glycol Chitosan-PEI Gene Carrier for MSCs

    • 2016 – 🧫 PAMAM Dendrimers for Gene Delivery to MSCs

    • 2012 – 🧬 DNA Methylation in Pluripotent Stem Cells

    • 2011 – 🧪 Stem Cell Substrate Physical Properties

    • 2011 – 🦷 Dental Stem Cell Comparisons

    • 2011 – 🔁 Dynamic Gene Copy Number Changes in iPSCs

    • 2010 – 🧬 Adipogenic Differentiation in Feeder Cells

    • 2010 – 🧬 Umbilical MSCs as Therapy

    • 2009 – 🦴 MSC Source Phenotypic Analysi

    • 2004 – ⚙️ Promyelocytic Leukemia & SAPK2 Inhibition

    • 2004 – 🦠 CMV and MHC Class I Immune Evasion

    • 2004 – 🛡️ HLA-G Shedding & NK Cell Inhibition

 🔍 Conclusion:

Dr. Sunray Lee’s consistent pursuit of excellence, coupled with tangible contributions to science, medicine, and technology, makes him not just a candidate—but a model recipient—for the Best Researcher Award. His innovative mindset, translational achievements, and leadership in stem cell applications mark him as a cornerstone in modern biomedical research 🧠🌱.